510(k) K111664
K111664 is an FDA 510(k) premarket notification submitted by Diazyme Laboratories for the device "DIAZYME CYSTATIN C POC TEST KIT". The FDA issued a decision of Substantially Equivalent on March 30, 2012. The device falls under product code NDY (Test, Cystatin C), a Class II device regulated under 21 CFR 862.1225. Diazyme Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 30, 2012
- Date Received
- June 14, 2011
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Test, Cystatin C
- Device Class
- Class II
- Regulation Number
- 862.1225
- Review Panel
- CH
- Submission Type